Align Technology, Inc. (“Align”) (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it has entered into a new accelerated stock repurchase agreement (“ASR”) with Citibank, N.A. (“Citi”), to repurchase $250 million of Align’s common stock under Align’s $1.0 billion stock repurchase program announced on May 13, 2021.
FDA-Approved Weight Loss Drug Plenity’s Parent Announces SPAC Deal: What Investors Should Know
A SPAC deal announced Monday could help accelerate the manufacturing of a promising weight loss drug targeting over 150 million people.
